NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered Tirzepatide from Mai Peptide? Mail in a sample (US only) and let us test it for free.

Test my supply
+5 more ↓
64%
Finnrick rating
#253 of 262 Tirzepatide vendors
16 of 27 classifiable tests passed
natural 59% · customers 4.5★ (17)
methodology · Purity focus
Finnrick analysis · Tirzepatide

Mai Peptide's tirzepatide record is pulled down by repeated purity misses, including a failed-identity/0 mg test and a Feb–Mar cluster below 99.5%. Recent results improved, but the latest +31% fill keeps the pattern volatile.

methodology →
vendor intelligence report
Vendor Intelligence Report: Mai Peptide

Corporate and B2B records tie the retail brand to a Xi’an operator, while archives show a predecessor identity and parked domain. Shared shop910 infrastructure, CDN assets, payment scripts, and cloned testimonials map a wider storefront cluster.

21 pages7 risk factors assessed12 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$0.77
84%
40
2
GHK-Cu
$0.06
81%
13
3
Ipamorelin
$0.90
77%
8
4
Tirzepatideselected
$0.33
64%
27
5
Tesamorelin
$2.20
59%
7
6
Cagrilintide
$2.40
56%
5
7
BPC-157
$0.70
45%
6
8
CJC-1295
$1.50
36%
3
9
TB-500
$1.20
36%
3
10
NAD+
$0.02
28%
3
11
Glutathione
$0.00
-
0
12
PT-141
-
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%25 Nov 2025: 74%17 Dec 2025: 75%1 Jan 2026: 77%9 Jan 2026: 74%15 Jan 2026: 75%19 Jan 2026: 76%29 Jan 2026: 77%2 Feb 2026: 73%2 Feb 2026: 69%2 Feb 2026: 65%2 Feb 2026: 62%2 Feb 2026: 58%4 Feb 2026: 60%4 Feb 2026: 61%18 Feb 2026: 58%4 Mar 2026: 55%6 Mar 2026: 57%6 Mar 2026: 58%6 Mar 2026: 60%6 Mar 2026: 61%8 Jun 2026: 64%1 Jul 2026: 65%30 Jul 2026: 63%21 Aug 2026: 60%4 Sep 2026: 62%7 Sep 2026: 63%18 Sep 2026: 64%29 Sep 2026: current 64%74%61%64%Nov 25Sep 26
Showing Tirzepatide tests only
Free peptide testing

Ordered Tirzepatide from Mai Peptide? Mail in a sample (US only) and let us test it for free.

Test my supply
Mai Peptide Tirzepatide test history
COA-backed lab tests
1-10 of 27

About Mai Peptide test results from Finnrick

Mai Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 10 peptides and 115 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Mai Peptide peptides in this dataset are BPC-157 (6 tests), Cagrilintide (5 tests) and CJC-1295 (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 115 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered Tirzepatide from Mai Peptide? Mail in a sample (US only) and let us test it for free.

Test my supply